Theriva Biologics, Inc.

Theriva Biologics, Inc.verified

TOVX

Price:

$1.7

Market Cap:

$4.73M

Theriva Biologics Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic organisms, the emergence of antimicrobial resistance (AMR), and acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant recipients; and SYN-020, a recombinant oral formulation for the enzyme intestinal alkaline phosphatase to treat both local GI and systemic diseases. It also develops...[Read more]

Industry

Biotechnology

IPO Date

2006-12-18

Stock Exchange

NYSE

Ticker

TOVX

The Enterprise Value as of December 2024 (TTM) for Theriva Biologics, Inc. (TOVX) is -9939835.00

According to Theriva Biologics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -9939835.00. This represents a change of -159.53% compared to the average of 16.70M of the last 4 quarters.

Theriva Biologics, Inc. (TOVX) Historical Enterprise Value (quarterly & annually)

How has TOVX Enterprise Value performed in the past?

The mean historical Enterprise Value of Theriva Biologics, Inc. over the last ten years is 1.14B. The current -9939835.00 Enterprise Value has changed -187.41% with respect to the historical average. Over the past ten years (40 quarters), TOVX's Enterprise Value was at its highest in in the March 2016 quarter at 5.34B. The Enterprise Value was at its lowest in in the December 2022 quarter at -32951109.70.

Quarterly (TTM)
Annual

Average

1.14B

Median

478.78M

Minimum

-33134166.70

Maximum

4.59B

Theriva Biologics, Inc. (TOVX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Theriva Biologics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 333.15%

Maximum Annual Enterprise Value = 4.59B

Minimum Annual Increase = -104.34%

Minimum Annual Enterprise Value = -33134166.70

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023-14100000.00-57.45%
2022-33134166.70-104.34%
2021763.56M333.15%
2020176.28M-9.13%
2019194.00M232.55%
201858.34M-96.38%
20171.61B-9.20%
20161.78B-61.33%
20154.59B105.02%
20142.24B29.52%

Theriva Biologics, Inc. (TOVX) Average Enterprise Value

How has TOVX Enterprise Value performed in the past?

The current Enterprise Value of Theriva Biologics, Inc. (TOVX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

238.78M

5-year avg

217.32M

10-year avg

1.14B

Theriva Biologics, Inc. (TOVX) Enterprise Value vs. Peers

How is TOVX’s Enterprise Value compared to its peers?

Theriva Biologics, Inc.’s Enterprise Value is less than Lumos Pharma, Inc. (24.19M), less than Diffusion Pharmaceuticals Inc. (10.58M), less than Avalo Therapeutics, Inc. (10.88M), less than Catalyst Biosciences, Inc. (1.01B), less than Panbela Therapeutics, Inc. (7.92M), less than Virpax Pharmaceuticals, Inc. (2.65M), less than Revelation Biosciences, Inc. (-4029924.00), less than Biodexa Pharmaceuticals Plc (775.53M), less than Praxis Precision Medicines, Inc. (1.27B), less than First Wave BioPharma, Inc. (2.80M), less than Salarius Pharmaceuticals, Inc. (-807852.00), less than SAB Biotherapeutics, Inc. (33.19M), less than Vaccinex, Inc. (311.44K), less than GeoVax Labs, Inc. (12.73M), less than Kintara Therapeutics, Inc. (7.08M), less than Fresh Tracks Therapeutics, Inc. (-6447751.00), less than Lisata Therapeutics, Inc. (6.65M), less than Marker Therapeutics, Inc. (21.16M), less than Exicure, Inc. (50.55M), less than Protagenic Therapeutics, Inc. (2.29M), less than PMV Pharmaceuticals, Inc. (40.53M),

Build a custom stock screener for Theriva Biologics, Inc. (TOVX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theriva Biologics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Theriva Biologics, Inc. (TOVX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Theriva Biologics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Theriva Biologics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Theriva Biologics, Inc. (TOVX)?

What is the 3-year average Enterprise Value for Theriva Biologics, Inc. (TOVX)?

What is the 5-year average Enterprise Value for Theriva Biologics, Inc. (TOVX)?

How does the current Enterprise Value for Theriva Biologics, Inc. (TOVX) compare to its historical average?